ASX:API Australian Pharmaceutical Industries (API) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Australian Pharmaceutical Industries Stock (ASX:API) 30 days 90 days 365 days Advanced Chart Ad InvestorPlaceWhat This Post-Election Shift Means for Your InvestmentsThe election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important.Click here now to watch the full briefing and prepare for what's next. Get API alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume453,647 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield2.29%Price TargetN/AConsensus RatingN/A Company OverviewAustralian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia.Read More… What This Post-Election Shift Means for Your Investments (Ad)The election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important.Click here now to watch the full briefing and prepare for what's next. Receive API Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Australian Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. Email Address API Stock News HeadlinesChemist Warehouse price rise warning after $8.8 billon deal greenlit: 'We will rue this day'November 7, 2024 | nz.finance.yahoo.comACCC clears Chemist Warehouse and Sigma’s $8.8b mega dealNovember 6, 2024 | msn.comWhat This Post-Election Shift Means for Your InvestmentsThe election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important.November 22, 2024 | InvestorPlace (Ad)Nasdaq Wrap: Reddit notches first ever profit; while an Aussie company leads Nasdaq’s winnersNovember 6, 2024 | msn.comCaliway Completed CBL-514 Phase 2b Study (CBL-0205) for Subcutaneous Fat ReductionOctober 24, 2024 | finance.yahoo.comElon Musk's xAI launched its own APIOctober 22, 2024 | msn.comM&A in the Pharma Contract Manufacturing Industry: 2024 Trends, Implications and OutlookOctober 4, 2024 | finance.yahoo.comFrost & Sullivan Released Report: "2024 Blue Book on Chinese Biopharmaceuticals Going Global: Current Status and Trends"September 28, 2024 | au.finance.yahoo.comSee More Headlines API Stock Analysis - Frequently Asked Questions How were Australian Pharmaceutical Industries' earnings last quarter? Australian Pharmaceutical Industries Limited (ASX:API) released its quarterly earnings results on Wednesday, April, 17th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by $0.00. What other stocks do shareholders of Australian Pharmaceutical Industries own? Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY) and Global X Cloud Computing ETF (CLOU). Company Calendar Last Earnings4/17/2019Today11/22/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorBusiness Services Industry Medical Equipment Wholesale Sub-IndustryComputer Software Current SymbolASX:API CUSIPN/A CIKN/A Webwww.api.net.au Phone+61-3-88553000FaxN/AEmployees1,310Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.28Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio71.32 Current Ratio1.20 Quick Ratio0.77 Sales & Book Value Annual Sales$4.00 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow8.26 Book ValueA$0.89 per share Price / BookN/AMiscellaneous Outstanding Shares492,656,000Free FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (ASX:API) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored1971, 1986, 1990… and right nowOne small investment into these three companies at IPO and you’ve outperformed almost any other investment you...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Australian Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Australian Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.